Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: FDA Orthopedic and Rehabilitation Devices Panel

This article was originally published in The Gray Sheet

Executive Summary

FDA Orthopedic and Rehabilitation Devices Panel: Jan. 12 meeting at FDA's Parklawn Building in Rockville, Maryland, will address reclassification petitions for non- and semi-constrained shoulders and uni- and total-patellofemorotibial knees. On Jan. 13, the advisory committee will discuss petitions on patellofemoral knees and constrained elbows, as well as classification of calcium sulfate pre-formed pellets (plaster of paris pellets). Written submissions for presentation at the meeting are due by Jan. 5; for more information contact panel secretary Jodi Nashman at 301/594-2036...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009298

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel